Balancing efficacy and financial toxicity in the management of metastatic castration-sensitive prostate cancer

被引：0
作者：
Sridhar, Srikala S. [1 ]
机构：
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2019年 / 13卷 / 12期
关键词：
THERAPY;
D O I：
10.5489/cuaj.6346
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：404 / 405
页数：2
相关论文
共 50 条
  • [31] Real-World Treatment Trends Among Patients with Metastatic Castration-Sensitive Prostate Cancer: Results from an International Study
    Barata, Pedro C.
    Leith, Andrea
    Ribbands, Amanda
    Montgomery, Rachel
    Last, Matthew
    Arondekar, Bhakti
    Ivanova, Jasmina
    Niyazov, Alexander
    [J]. ONCOLOGIST, 2023, 28 (09) : 780 - 789
  • [32] Combination Androgen Receptor Inhibition and Docetaxel in Metastatic Castration-sensitive Prostate Cancer: The Next Step in First-line Treatment?
    Adashek, Jacob J.
    Reed, Jarred P.
    Tandon, Ankita
    Freedland, Stephen J.
    Posadas, Edwin
    Bhowmick, Neil
    Chung, Leland W.
    Freeman, Michael
    Figlin, Robert A.
    Gong, Jun
    [J]. CLINICAL GENITOURINARY CANCER, 2020, 18 (06) : 425 - 428
  • [33] Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naive Castration-sensitive Metastatic Prostate Cancer
    Akamatsu, Shusuke
    Kubota, Masashi
    Uozumi, Ryuji
    Narita, Shintaro
    Takahashi, Masahiro
    Mitsuzuka, Koji
    Hatakeyama, Shingo
    Sakurai, Toshihiko
    Kawamura, Sadafumi
    Ishidoya, Shigeto
    Hoshi, Senji
    Ishida, Masanori
    Mizuno, Kei
    Ogura, Keiji
    Goto, Takayuki
    Terada, Naoki
    Kobayashi, Takashi
    Yamasaki, Toshinari
    Inoue, Takahiro
    Tsuchiya, Norihiko
    Ohyama, Chikara
    Arai, Yoichi
    Habuchi, Tomonori
    Morita, Satoshi
    Ogawa, Osamu
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (03): : 320 - 328
  • [34] MANAGEMENT OF NON METASTATIC CASTRATION RESISTANT PROSTATE CANCER
    Munoz-Velez, Daniel
    [J]. ARCHIVOS ESPANOLES DE UROLOGIA, 2015, 68 (02): : 125 - 134
  • [35] Comparison of prostate-specific antigen response in patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or abiraterone acetate: A retrospective cohort study
    Lowentritt, Benjamin
    Pilon, Dominic
    Waters, Dexter
    Rossi, Carmine
    Muser, Erik
    Kurteva, Siyana
    Shah, Aditi
    Khilfeh, Ibrahim
    Du, Shawn
    Ellis, Lorie
    Lefebvre, Patrick
    Brown, Gordon
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (05) : 252.e19 - 252.e27
  • [36] Population-Based Study of Docetaxel or Abiraterone Effectiveness and Predictive Markers of Progression Free Survival in Metastatic Castration-Sensitive Prostate Cancer
    Briones, Juan
    Khan, Maira
    Sidhu, Amanjot K.
    Zhang, Liying
    Smoragiewicz, Martin
    Emmenegger, Urban
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [37] The Impact of Radiotherapy on the Primary Tumor in Patients with Metastatic High-Volume Castration-Sensitive Prostate Cancer: A Propensity Score Matching Analysis
    Skripai, Antoni
    Blumenfeld, Philip
    Krakow, Aaron
    Den, Robert
    Popovtzer, Aron
    Wygoda, Marc
    Michaeli, Tal Falick
    [J]. CANCERS, 2025, 17 (02)
  • [38] Timing of androgen deprivation monotherapy and combined treatments in castration-sensitive and castration-resistant prostate cancer: a narrative review
    Kunath, F.
    Goebell, P. J.
    Wullich, B.
    Sikic, D.
    Kahlmeyer, A.
    [J]. WORLD JOURNAL OF UROLOGY, 2020, 38 (03) : 601 - 611
  • [39] Single-nucleotide polymorphism associations with efficacy and toxicity in metastatic castration-resistant prostate cancer treated with cabazitaxel
    Herrero Rivera, Daniel
    Garrigos Vacas, Carmen
    Marcos Kovandzic, Laura
    Puente Vazquez, Javier
    Alonso, Lucia A.
    Mellado Gonzalez, Begona
    Calderero Aragon, Veronica
    Grande, Enrique
    Luque Caro, Raquel
    Virizuela Echaburu, Juan A.
    Rodriguez Moreno, Juan F.
    Etxebarria, Ainara A.
    Rodriguez-Antona, Cristina
    Duran, Ignacio
    [J]. PHARMACOGENOMICS, 2022, 23 (11) : 627 - 638
  • [40] Comparative assessment of docetaxel for safety and efficacy between hormone-sensitive and castration-resistant metastatic prostate cancer
    Mager, Rene
    Savko, Olga
    Boehm, Katharina
    Thomas, Anita
    Dotzauer, Robert
    Borgmann, Hendrik
    Jaeger, Wolfgang
    Thomas, Christian
    Haferkamp, Axel
    Hoefner, Thomas
    Tsaur, Igor
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (12) : 999 - 1005
12345